Rchr
J-GLOBAL ID:201801017893891623   Update date: Mar. 30, 2024

Takata Miyako

Takata Miyako
Affiliation and department:
Research field  (1): Respiratory medicine
Research theme for competitive and other funds  (8):
  • 2021 - 2024 COVID-19に対する可溶性ULBP2制御によるNK細胞療法の開発
  • 2020 - 2024 非結核性抗酸菌症と腸内細菌叢の関わりについて
  • 2018 - 2022 Development of a novel surveillance system integrating local and global AMR information
  • 2014 - 2018 A novel therapy for sepsis by regulating soluble ULBP2
  • 2014 - 2018 Development of the new clinical cure to overcome pemetrexed tolerance for malignant pleural mesothelioma
Show all
Papers (24):
more...
Patents (1):
  • EGFR遺伝子変異検出プライマーセット、それを含むEGFR遺伝子変異検出キット、およびそれを用いてEGFR遺伝子変異検出を行うための核酸増幅装置
Professional career (1):
  • 医学博士 (鳥取大学)
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page